insights_auto
Why is SYRE down 3,62%?
Dive Deeperchevron_right
SYRE:NASDAQ
Spyre Therapeutics Inc
94,10 US$
arrow_downward
-3,62%(-3,53) 1D
20 ნოე, 13:06:52 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYRE...
Open
95,93 US$
High
99,56 US$
Low
93,95 US$
Mkt. cap
8,94 მლრდ.
Avg. vol.
1,05 მლნ.
Volume
283,47 ათ.
52-wk high
110,64 US$
52-wk low
23,01 US$
EPS
-3,22 US$
Beta
3,24
Shares outstanding
94,97 მლნ.
No. of employees
130
Open
95,93 US$
High
99,56 US$
Low
93,95 US$
Mkt. cap
8,94 მლრდ.
Avg. vol.
1,05 მლნ.
Volume
283,47 ათ.
52-wk high
110,64 US$
52-wk low
23,01 US$
EPS
-3,22 US$
Beta
3,24
Shares outstanding
94,97 მლნ.
No. of employees
130
News stories
From web sources and news partners
Investing.com UK
·
3 დღის წინ
Spyre at Jefferies Global Healthcare Conference: combo strategy in focus By Investing.com
About Spyre Therapeutics Inc
CEO-
Employees130
Founded1 იან. 2013
HeadquartersWaltham, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitespyre.com